Physician profile
Steven A Kooperman
NPI 1225036577
$3,416.68
in general payments reported to CMS, 2019-2025
32 companies · $18.72 in 2025
The $18.72 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $390 · 2020: $366 · 2021: $570 · 2022: $802 · 2023: $760 · 2024: $510 · 2025: $18.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,203 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,203.30 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $540.60 | 2019-2024 | Prolia, Evenity |
| Abbvie INC. | $411.49 | 2019-2023 | |
| Hologic Sales and Service, LLC | $242.50 | 2019-2025 | Aptima, Myosure Tissue Removal Device, Affirm Prone Biopsy System |
| Sumitomo Pharma America, INC. | $226.94 | 2023-2024 | Myfembree |
| Astellas Pharma US INC | $221.32 | 2022-2024 | Veozah, Myrbetriq |
| Aspira Women'S Health INC | $163.33 | 2020-2022 | |
| Therapeuticsmd, INC. | $163.07 | 2019-2022 | |
| Gynesonics, INC. | $152.79 | 2022 | |
| Exeltis, USA INC. | $151.12 | 2019-2024 | Slynd |
| Myovant Sciences INC. | $136.06 | 2021-2022 | |
| Pfizer INC. | $128.22 | 2019-2024 | |
| Agile Therapeutics, INC. | $110.32 | 2021-2023 | Twirla |
| Mayne Pharma Commercial LLC | $98.98 | 2021-2024 | |
| Coopersurgical, INC. | $95.48 | 2019-2024 | Paragard T 380a, Paragard T 380a |
| Organon LLC | $62.03 | 2021-2024 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $59.28 | 2020-2023 | Balcoltra |
| Merck Sharp & Dohme LLC | $51.01 | 2020-2024 | Gardasil 9, Gardasil |
| Amag Pharmaceuticals, INC. | $48.52 | 2019 | |
| Minerva Surgical, INC | $48.18 | 2019 | |
| Scynexis, INC. | $41.86 | 2022 | |
| Exact Sciences Corporation | $35.60 | 2023-2024 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $34.01 | 2024 | |
| Lupin INC. | $29.80 | 2020 | |
| Allergan, INC. | $26.43 | 2019 | |
| Medicem INC. | $25.15 | 2020 | |
| Becton, Dickinson and Company | $24.58 | 2023 | Bd Onclarity |
| Millicent US INC | $21.85 | 2024 | Femring, Intrarosa |
| Mylan Pharmaceuticals INC. | $14.43 | 2020 | |
| Lilly USA, LLC | $14.05 | 2021 | |
| Medtronic, INC. | $13.22 | 2023 | Venaseal |
| Dysis Medical, INC. | $13.03 | 2019 | |
| Tactile Systems Technology INC | $11.43 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Kooperman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.